The combination of imaging examination and serum tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen19-9 (CA19-9), remains the routine monitoring approach for recurrence detection in CRC patients after radical surgery [5–10]. The gene discussed is CEACAM5; the disease is neoplasm.